Article
Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules
10 May 2022
Abstract excerpt
Bispecific T cell receptor (TCR)-based molecules capable of redirecting and activating T cells towards tumor cells represent a novel and promising class of biotherapeutics for the treatment of cancer. Usage of TCRs allows for targeting of intracellularly expressed and highly selective cancer antigens, but also requires a complex maturation process to increase the naturally low affinity and stability of TCRs. Even...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
